{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:25:29Z","timestamp":1790778329274,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T00:00:00Z","timestamp":1493510400000},"content-version":"vor","delay-in-days":119,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2017]]},"DOI":"10.6061\/clinics\/2017(04)07","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T08:11:00Z","timestamp":1494490260000},"page":"231-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment"],"prefix":"10.1016","volume":"72","author":[{"given":"Adriano L.","family":"Spirlandeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Dick-de-Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Zamarioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Jorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra N.Z.","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello H.","family":"Nogueira-Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose B.","family":"Volpon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alceu A.","family":"Jord\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Q.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Y.","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.A.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.6061\/clinics\/2017(04)07_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/BOR.0000000000000074","article-title":"Secondary osteoporosis and metabolic bone disease in patients 50 years and older with osteoporosis or with a recent clinical fracture: a clinical perspective","volume":"26","author":"Bours","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"19-20","key":"10.6061\/clinics\/2017(04)07_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10354-008-0594-z","article-title":"Cholestasis and metabolic bone disease - a clinical review","volume":"158","author":"Gasser","year":"2008","journal-title":"Wien Med Wochenschr"},{"issue":"3","key":"10.6061\/clinics\/2017(04)07_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s12072-010-9194-2","article-title":"Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study","volume":"4","author":"Miroliaee","year":"2010","journal-title":"Hepatol Int"},{"issue":"11","key":"10.6061\/clinics\/2017(04)07_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081652","article-title":"Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C","volume":"8","author":"Orsini","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"10.6061\/clinics\/2017(04)07_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002239900622","article-title":"Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease","volume":"64","author":"Crosbie","year":"1999","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.6061\/clinics\/2017(04)07_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1399-3046.2002.01060.x","article-title":"Hepatic osteodystrophy in chronic cholestasis: evidence for a multifactorial etiology","volume":"6","author":"Klein","year":"2002","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.6061\/clinics\/2017(04)07_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1440-1746.1996.tb00284.x","article-title":"Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis","volume":"11","author":"Chen","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.6061\/clinics\/2017(04)07_bib8","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","volume":"95","author":"Janes","year":"1995","journal-title":"J Clin Invest"},{"issue":"6","key":"10.6061\/clinics\/2017(04)07_bib9","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/hep.26696","article-title":"Strengthening the bones in primary biliary cirrhosis","volume":"58","author":"Angulo","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.6061\/clinics\/2017(04)07_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2265.2007.02765.x","article-title":"Impairment of bone mass development in children with chronic cholestatic liver disease","volume":"66","author":"de Albuquerque Taveira","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10.6061\/clinics\/2017(04)07_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1590\/S0100-879X2010007500118","article-title":"Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease","volume":"43","author":"Taveira","year":"2010","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.6061\/clinics\/2017(04)07_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00223-009-9249-3","article-title":"Etiopathogenesis of hepatic osteodystrophy in Wistar rats with cholestatic liver disease","volume":"85","author":"Pereira","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.6061\/clinics\/2017(04)07_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","article-title":"Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat","volume":"46","author":"Abe","year":"2007","journal-title":"J Hepatol"},{"issue":"3","key":"10.6061\/clinics\/2017(04)07_bib14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.23421","article-title":"Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans","volume":"51","author":"Moreno","year":"2010","journal-title":"Hepatology"},{"issue":"16","key":"10.6061\/clinics\/2017(04)07_bib15","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.jbiomech.2008.09.028","article-title":"Bisphosphonate treatment in the oim mouse model alters bone modeling during growth","volume":"41","author":"Rao","year":"2008","journal-title":"J Biomech"},{"issue":"3","key":"10.6061\/clinics\/2017(04)07_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00223-011-9505-1","article-title":"VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender-specific manner","volume":"89","author":"de Paula","year":"2011","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"10.6061\/clinics\/2017(04)07_bib17","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.6061\/clinics\/2017(04)07_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4939-2895-8_8","article-title":"Glucocorticoid-Induced Osteoporosis","volume":"872","author":"Frenkel","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.6061\/clinics\/2017(04)07_bib19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1590\/S0100-879X2012007500143","article-title":"Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats","volume":"45","author":"Pereira","year":"2012","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.6061\/clinics\/2017(04)07_bib20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00204-013-1191-5","article-title":"Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis","volume":"88","author":"Nussler","year":"2014","journal-title":"Arch Toxicol"},{"issue":"2","key":"10.6061\/clinics\/2017(04)07_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bone.2013.03.012","article-title":"Modeling hepatic osteodystrophy in Abcb4 deficient mice","volume":"55","author":"Hochrath","year":"2013","journal-title":"Bone"},{"issue":"10","key":"10.6061\/clinics\/2017(04)07_bib22","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/liv.12819","article-title":"Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction","volume":"35","author":"Lai","year":"2015","journal-title":"Liver Int"},{"issue":"3","key":"10.6061\/clinics\/2017(04)07_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00223-008-9104-y","article-title":"Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro","volume":"82","author":"Idris","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"18","key":"10.6061\/clinics\/2017(04)07_bib24","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","article-title":"Osteoblast proliferation and maturation by bisphosphonates","volume":"25","author":"Im","year":"2004","journal-title":"Biomaterials"},{"issue":"5","key":"10.6061\/clinics\/2017(04)07_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.arcmed.2013.05.002","article-title":"Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells","volume":"44","author":"Casado-Diaz","year":"2013","journal-title":"Arch Med Res"},{"issue":"7","key":"10.6061\/clinics\/2017(04)07_bib26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00228-012-1216-7","article-title":"Bisphosphonates: effects on osteoblast","volume":"68","author":"Maruotti","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.6061\/clinics\/2017(04)07_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00198-010-1353-8","article-title":"Effects of risedronate on bone marrow adipocytes in postmenopausal women","volume":"22","author":"Duque","year":"2011","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.6061\/clinics\/2017(04)07_bib28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jcms.2010.10.007","article-title":"Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner\u2013a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2","volume":"39","author":"Koch","year":"2011","journal-title":"J Craniomaxillofac Surg"},{"issue":"6","key":"10.6061\/clinics\/2017(04)07_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/labinvest.3700539","article-title":"FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2","volume":"87","author":"Hattori","year":"2007","journal-title":"Lab Invest"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222009851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222009851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:56:03Z","timestamp":1761720963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222009851"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322017000400231&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5401620\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["S1807593222009851"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2017(04)07","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2017(04)07","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}